Estimation of utility weights for major liver diseases according to disease severity in Korea

Ock, Minsu; Lim, So Yun; Lee, Hyeon-Jeong; Kim, Seon-Ha; Jo, Min-Woo

doi:10.1186/s12876-017-0660-3

BMC Gastroenterology

Table 5 Utility weights according to socio-demographic and health condition factors

From: Estimation of utility weights for major liver diseases according to disease severity in Korea

		Chronic hepatitis B virus infection		Chronic hepatitis C virus infection		Non-alcoholic steatohepatitis		Liver cirrhosis		HCC that requires a partial hepatectomy		HCC that requires non-surgical treatments		HCC that requires a liver transplantation		HCC that requires palliative therapy
		VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG	VAS	SG
Gender	Man	0.60	0.77	0.58	0.74	0.58	0.77	0.36	0.55	0.35	0.60	0.30	0.51	0.47	0.63	0.19	0.44
Gender	Woman	0.59	0.75	0.59	0.73	0.58	0.73	0.38	0.56	0.37	0.59	0.29	0.57	0.47	0.59	0.20	0.46
Age group	19-29	0.60	0.78	0.59	0.75	0.56	0.78	0.38	0.50	0.37	0.57	0.30	0.51	0.51	0.60	0.20	0.44
	30-39	0.56	0.82	0.59	0.81*	0.61	0.82	0.36	0.59	0.33	0.64	0.30	0.54	0.48	0.67	0.17	0.43
	40-49	0.58	0.66	0.63	0.62*	0.59	0.65	0.44**	0.52	0.40	0.54	0.34	0.55	0.54**	0.54	0.25	0.44
	50-59	0.57	0.76	0.59	0.69	0.51	0.77	0.35	0.50	0.32	0.59	0.27	0.49	0.43	0.62	0.19	0.44
	≥60	0.67	0.78	0.55	0.79	0.61	0.75	0.29**	0.63	0.38	0.65	0.29	0.60	0.41**	0.64	0.18	0.51
Education level	High school or below	0.60	0.75	0.59	0.73	0.59	0.75	0.37	0.54	0.36	0.59	0.30	0.54	0.47	0.31	0.19	0.45
Education level	College or above	0.58	0.81	0.59	0.74	0.54	0.77	0.36	0.59	0.34	0.62	0.29	0.54	0.47	0.29	0.20	0.45
Occupation	Manual	0.60	0.75	0.58	0.71	0.58	0.74	0.35	0.52	0.35	0.58	0.31	0.53	0.48	0.59	0.19	0.43
	Non-manual	0.58	0.76	0.59	0.72	0.57	0.75	0.39	0.59	0.35	0.58	0.27	0.54	0.52	0.67	0.21	0.47
	Others	0.61	0.80	0.59	0.77	0.58	0.78	0.38	0.58	0.39	0.65	0.31	0.57	0.43	0.63	0.19	0.48
Monthly income	Less than 2.5 million won	0.67*	0.77	0.55	0.72	0.60	0.75	0.32	0.55	0.37	0.61	0.29	0.52	0.43	0.63	0.19	0.42
	2.5-5.0 million won	0.56*	0.76	0.60	0.72	0.56	0.76	0.37	0.56	0.36	0.60	0.29	0.56	0.48	0.62	0.18	0.45
	More than 5.0 million won	0.62	0.76	0.59	0.76	0.59	0.74	0.38	0.54	0.35	0.57	0.31	0.53	0.47	0.59	0.23	0.48
Ambulatory care visit in past 2 weeks	Yes	0.54	0.75	0.52*	0.69	0.60	0.76	0.31	0.54	0.34	0.63	0.29	0.58	0.39	0.66	0.18	0.45
Ambulatory care visit in past 2 weeks	No	0.60	0.76	0.60*	0.74	0.57	0.75	0.37	0.55	0.36	0.59	0.30	0.54	0.48	0.61	0.20	0.45
Hospitalization in past 12 months	Yes	0.54	0.55	0.53	0.29	0.81	0.62	0.34	0.38	0.43	0.47	0.35	0.78	0.42	0.49	0.19	0.47
Hospitalization in past 12 months	No	0.60	0.77	0.59	0.74	0.57	0.76	0.37	0.56	0.36	0.60	0.30	0.54	0.47	0.62	0.19	0.45
Morbidity	Yes	0.67	0.79	0.57	0.70	0.56	0.80	0.35	0.61	0.37	0.59	0.30	0.54	0.43	0.63	0.17	0.45
Morbidity	No	0.59	0.76	0.59	0.73	0.58	0.75	0.37	0.54	0.36	0.60	0.30	0.54	0.47	0.61	0.20	0.45

VAS visual analogue scale, SG standard gamble, HBV hepatitis B virus, HCV hepatitis C virus, HCC hepatocellular carcinoma
*P-value < 0.05; **P-value < 0.01

Back to article page

ISSN: 1471-230X

Contact us

Submission enquiries: bmcgastroenterology@biomedcentral.com
General enquiries: ORSupport@springernature.com